Iu C, Clinical Research Excellence Application and Research Center

Stanbul 34098

0 studies enrolling now · 1 studies all time

What they study most

Gastric, or Gastroesophageal Junction Adenocarcinoma

Studies at this site

• Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction Carcinoma — Completed